Top Marijuana Stocks from the NASDAQ

Top Marijuana Stocks from the NASDAQ

Although the almost all U.S.-based cannabis businesses and lots of foreign American Depository Receipts (ADRs) trade within the countertop (OTC), a marijuana that is few are exchanged from the NASDAQ. Some investors choose shares which are noted on the NASDAQ to many other exchanges because of the increased liquidity and tighter spreads when compared to markets that are over-the-counter. As an example, because the cannabis industry is continuing to grow in present months and years, uplisting from an OTC market to an established U.S. change happens to be a banner achievement for several increasing marijuana organizations. (For associated reading, see “Understanding healthcare Cannabis vs. Recreational Cannabis Stocks”)

An increasing amount of marijuana organizations are increasingly being noted on reputable U.S. exchanges instead of being exchanged in the OTC market showing the fast development of the cannabis industry.

NASDAQ-listed Marijuana shares

The NASDAQ had been 1st electronic trade and is definitely similar to technology and biotechnology. The cannabis businesses in the NASDAQ reflect this, while the greater part of them run when you look at the biotech area of this industry. Here you will find the marijuana that is NASDAQ-listed, in alphabetical purchase, at the time of October 26, 2019, with a failure of the total returns.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Arena Pharmaceuticals is a biotech business active in the manufacturing of medical marijuana drugs. Research and development around Arena’s APD371 could be the focus that is primary of company’s cannabis biotech initiatives.

Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)

Atlantic Alliance Partnership Corp. is a check that is blank that is in a merger contract with Kalyx developing Inc. Kalyx is a respected owning a home rely upon the regulated cannabis industry in the usa.

Key Takeaways

  • The cannabis industry, specially the section of cannabis and biotech, is attracting substantial investor attention.
  • Cannabis will be found in brand new medications to treat discomfort and numerous chronic, inflammatory, and fibrotic conditions.
  • Businesses will also be developing cannabinoid products for autism range problems, schizophrenia, glioma, Tourette problem, epileptic problems, Prader-Willi Syndrome (an inherited condition), and addiction that is amphetamine.

Cara Therapeutics Inc. (NASDAQ:CARA)

Cara Therapeutics is really a clinical-stage biotechnology business focused on developing and commercializing new chemical entities for the indications of discomfort and pruritus (itching). Although all the company’s clinical-stage items target opioid receptors, Cara happens to be performing research that is preclinical cannabinoids for the treating neuropathic pain.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)

Corbus Pharmaceuticals Holdings Inc. is just a cannabis biotech company. The team’s research, development, and production are based around cannabis drugs that look for to take care of chronic, inflammatory, fibrotic, along with other conditions.

Cronos Group Inc. (NASDAQ:CRON)

Cronos Group Inc. is really a cannabis that are canadian. The team owns and seeks cannabis-related subsidiaries and licensed manufacturers. In December of 2018, Marlboro maker Altria announced intends to invest $1.8 billion in Cronos. The investment has provided Cronos not just with extra money to finance its continued expansion but in addition having a partner that is well-established into the advertising of customer brands.

Greenlane Holdings Inc. (NASDAQ:GNLN)

Greenlane Holdings Inc. is really a Boca Raton, Florida-based cannabis business. It distributes many different cannabis usage add-ons and vaporization gear and items to customers that are retail the U.S. and Canada. Also, it runs websites that are e-commerce additional product product sales.

GW Pharmaceuticals Plc. (NASDAQ:GWPH)

GW Pharmaceuticals is having a profile of cannabinoid medications. These medicines consist of Sativex for the treating spasticity linked to numerous sclerosis and cancer tumors discomfort and Epidiolex for the treating youth epilepsy. Sativex is commercialized much more than the usual dozen nations away from united states of america and has now received approval that is regulatory various other nations. Epidiolex received Food And Drug Administration approval as a treatment plan for Dravet Syndrome and Lennox-Gastaut Syndrome, two types of serious, very very early onset epilepsy without good current treatment plans. Other indications reveal that GW Pharmaceuticals is developing cannabinoid items for autism range problems, schizophrenia, and glioma.

Intec Pharma Ltd. (NASDAQ:NTEC)

Intec Pharma is just a clinical-stage biopharmaceutical business that is developing medications according to its proprietary Accordion Pill technology. Intec’s product pipeline includes cannabinoid-based medications for lower pain that is back fibromyalgia.

Marrone Bio Innovations, Inc. (NASDAQ:MBII)

Marrone Bio Innovations, Inc. develops and distributes environmentally responsible bio-based pest administration and plant wellness items. In 2017, Marrone Bio Innovations announced that three MBII active ingredients are now legal to be used on cannabis plants when you look at the Ca cultivation market.

Modern Age Beverages Corp. (NASDAQ:NBEV)

Modern Beverages Corp. is really a maker of beverages produced from yerba mate, green tea leaf, kombucha, and comparable services and products. In current months, modern age has expanded its beverage offerings to incorporate CBD infusions also, bringing it in to the orbit of cannabis shares.

OrganiGram Holdings Inc. (NASDAQ:OGI)

Canadian cannabis producer OrganiGram Holdings Inc. debuted regarding the NASDAQ in might of 2019, rendering it very present cannabis businesses to record regarding the popular change. The business happens to be rapidly expanding its manufacturing ability and might have the ability to create just as much as 113,000 kilograms of item per 12 months because of the end of 2019.

Psychemedics Corporation (NASDAQ:PMD)

Psychemedics Corporation runs within the enforcement sector. The business’s business operations support drug screening through hair examples.

Sundial Growers Inc. (NASDAQ:SNDL)

Alberta, Canada-based Sundial Growers Inc. is another new entry on the NASDAQ change. The cannabis producer made headlines in October of 2019 (and saw a short cost boost) when it announced the release of an innovative new Palmetto model of recreational cannabis, first for sale in Saskatchewan and Manitoba.

Therapix Biosciences Ltd. (NASDAQ:TRPX)

Therapix Biosciences Ltd. is just a specialty clinical-stage pharmaceutical company concentrated in the growth of cannabinoid-based medications. Therapix’s present pipeline includes items targeted to treat Tourette syndrome and mild impairment that is cognitive.

Tilray Inc. (NASDAQ:TLRY)

Tilray Inc. had been 1st marijuana-related business to have a short general general public providing (IPO) in the us. The Nanaimo, Vancouver company that is island-based on medical cannabis services and products.

Village Farms Global (NASDAQ:VFF)

Village Farms Overseas is considered the most current cannabis stock to begin dealing from the NASDAQ. The business’s stocks became readily available for trade on February 21, 2019. The organization includes a history that is decades-long greenhouse produce manufacturing and contains just recently shifted a few of its focus toward cannabis production.

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)

Zynerba Pharmaceuticals is targeted regarding the growth of synthetic cannabinoid remedies for transdermal (through your skin) delivery. Their pipeline currently includes two medications being developed for indications epilepsy that is including osteoarthritis, fibromyalgia, peripheral neuropathic discomfort, and Fragile X syndrome.